Cargando…
Chitosan–Hyaluronic Acid Nanoparticles for Active Targeting in Cancer Therapy
Cancer is the most common cause of death worldwide; therefore, there is a need to discover novel treatment modalities to combat it. One of the cancer treatments is nanoparticle technology. Currently, nanoparticles have been modified to have desirable pharmacological effects by using chemical ligands...
Autores principales: | Puluhulawa, Lisa Efriani, Joni, I Made, Elamin, Khaled M., Mohammed, Ahmed Fouad Abdelwahab, Muchtaridi, Muchtaridi, Wathoni, Nasrul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416118/ https://www.ncbi.nlm.nih.gov/pubmed/36015667 http://dx.doi.org/10.3390/polym14163410 |
Ejemplares similares
-
Monoclonal antibody as a targeting mediator for nanoparticle targeted delivery system for lung cancer
por: Wathoni, Nasrul, et al.
Publicado: (2022) -
Hyaluronic Acid-Coated Chitosan Nanoparticles as an Active Targeted Carrier of Alpha Mangostin for Breast Cancer Cells
por: Meylina, Lisna, et al.
Publicado: (2023) -
The Use of Megamolecular Polysaccharide Sacran in Food and Biomedical Applications
por: Puluhulawa, Lisa Efriani, et al.
Publicado: (2021) -
Chitosan-Based Nanoparticles of Targeted Drug Delivery System in Breast Cancer Treatment
por: Herdiana, Yedi, et al.
Publicado: (2021) -
Nanoformulations of α-Mangostin for Cancer Drug Delivery System
por: Meylina, Lisna, et al.
Publicado: (2021)